TCRT Stock — Alaunos Therapeutics Inc.: Cash, EV, Pipeline

Share price

$1.20

Market cap

$3.0M

Cash

$0.1M

Enterprise value

$2.9M

Balance sheet

Cash	$0.1M
Debt	$0.0M
Net cash	$0.1M
Enterprise value	$2.9M
Basic shares	2.5M shares
Fully diluted shares	3.1M shares
Fully diluted market cap	$3.8M
Cash per share	$0.05

Cash figures as of 2026-06-30. Database snapshot: 2026-09-21.

Price history

Loading TCRT daily closes…

Loading price history…

Pipeline assets

ALN1003

Preclinical · Active Modality: Oral small molecule

Indications

Metabolic syndrome and related conditions (obesity, MASLD, insulin resistance) (Preclinical)

Status note Internally developed candidate in the early-preclinical Obesity and Metabolic Disorders Program; company is advancing it through additional studies, formulation optimization and manufacturing scale-up toward IND-enabling activities. Legacy TCR-T assets are subject only to limited ongoing efforts to monetize remaining intellectual property.

Per-asset detail extracted from the 10-Q filed 2026-08-14. Fields the filing does not state are marked "not disclosed" rather than filled from other sources.

No lead program on file for this company.

Active clinical trials

Trial	Phase	Status	Role	Sponsor	BP	Condition(s)	Mgmt guide
NCT01492036	Not disclosed	Recruiting	Collaborator	M.D. Anderson Cancer Center	—	Retroviridae Infections; Cancer	—

Sponsor-matched active trials from ClinicalTrials.gov (0 as sponsor, 1 as collaborator); "Sponsor" = company is the lead sponsor, "Collaborator" = company is a collaborator. The BP column flags big-pharma involvement as lead sponsor or collaborator (excluding the company itself). The Mgmt guide column shows what management guided for readout timing when a guided program matches the trial (hover for the quote, click for the source). Trial listings are not a company pipeline slide.

View all 1 active trials for M.D. Anderson Cancer Center on ClinicalTrials.gov

No specialist-fund holders in 13F data for this company.

TCRT — Alaunos Therapeutics Inc.

Balance sheet

Price history

Pipeline assets

Active clinical trials